Mesoblast Ltd
ASX:MSB

Watchlist Manager
Mesoblast Ltd Logo
Mesoblast Ltd
ASX:MSB
Watchlist
Price: 1.62 AUD -4.71% Market Closed
Market Cap: 2.1B AUD

Intrinsic Value

The intrinsic value of one MSB stock under the Base Case scenario is 1 AUD. Compared to the current market price of 1.62 AUD, Mesoblast Ltd is Overvalued by 38%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MSB Intrinsic Value
1 AUD
Overvaluation 38%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Mesoblast Ltd

Valuation History Unavailable

Historical valuation for MSB cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Mesoblast Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Mesoblast Ltd

Current Assets 69.7m
Cash & Short-Term Investments 37.7m
Receivables 3m
Other Current Assets 29m
Non-Current Assets 583.6m
Long-Term Investments 1.2m
PP&E 6.2m
Intangibles 574.9m
Other Non-Current Assets 1.3m
Efficiency

Free Cash Flow Analysis
Mesoblast Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Mesoblast Ltd

Revenue
5.7m USD
Cost of Revenue
5.8m USD
Gross Profit
11.4m USD
Operating Expenses
-91.6m USD
Operating Income
-80.2m USD
Other Expenses
-23.2m USD
Net Income
-103.4m USD
Fundamental Scores

MSB Profitability Score
Profitability Due Diligence

Mesoblast Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Exceptional Revenue Growth Forecast
Declining ROIC
Declining ROE
Negative 1-Year Revenue Growth
18/100
Profitability
Score

Mesoblast Ltd's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

MSB Solvency Score
Solvency Due Diligence

Mesoblast Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Low D/E
Short-Term Solvency
68/100
Solvency
Score

Mesoblast Ltd's solvency score is 68/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MSB Price Targets Summary
Mesoblast Ltd

Wall Street analysts forecast MSB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MSB is 2.96 AUD with a low forecast of 2.42 AUD and a high forecast of 3.57 AUD.

Lowest
Price Target
2.42 AUD
50% Upside
Average
Price Target
2.96 AUD
83% Upside
Highest
Price Target
3.57 AUD
120% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Mesoblast Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for MSB is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

MSB Insider Trading
Buy and sell transactions by insiders

MSB News

Other Videos
What is the Intrinsic Value of one MSB stock?

The intrinsic value of one MSB stock under the Base Case scenario is 1 AUD.

Is MSB stock undervalued or overvalued?

Compared to the current market price of 1.62 AUD, Mesoblast Ltd is Overvalued by 38%.

Back to Top